Clinical trial of coagulase and alpha-haemolysin toxoids in chronic furunculosis.
作者信息
HARRISON K J
出版信息
Br Med J. 1963 Jul 20;2(5350):149-52. doi: 10.1136/bmj.2.5350.149.
Abstract
摘要
相似文献
1
Clinical trial of coagulase and alpha-haemolysin toxoids in chronic furunculosis.
Br Med J. 1963 Jul 20;2(5350):149-52. doi: 10.1136/bmj.2.5350.149.
2
The preparation and properties of staphylocoagulase toxoid.
J Pathol Bacteriol. 1963 Apr;85:341-8. doi: 10.1002/path.1700850211.
3
USE OF STAPHYLOCOCCUS TOXOID AND AUTOGENOUS VACCINE IN THE TREATMENT OF BOILS.
N C Med J. 1963 Sep;24:385-6.
4
FURTHER OBSERVATIONS ON ANTIBACTERIAL IMMUNITY TO STAPHYLOCOCCUS PYOGENS IN RABBITS.
Br J Exp Pathol. 1964 Jun;45(3):256-63.
5
THE PROTECTION OF RABBITS AGAINST INFECTION WITH STAPHYLOCOCCI BY IMMUNISATION WITH STAPHYLOCOAGULASE TOXIN OR TOXOID.
J Pathol Bacteriol. 1964 Jan;87:145-50.
6
TOXOID FORMATION OF PNEUMOLYSIN AND STREPTOLYSIN O BY GLUCURONAMIDE.
Nagoya J Med Sci. 1965 Jul;27:209-17.
7
Studies with staphylococcal toxins. V. Possible identification of alpha hemolysin with a proteolytic enzyme.
Can J Microbiol. 1960 Apr;6:183-94. doi: 10.1139/m60-020.
8
[APROPOS OF A FEW CASES FURUNCULOSIS].
J Sci Med Lille. 1963 Dec;81:603-7.
9
10
Studies on the pathogenesis of staphylococcal infection. V. Purification and characterization of staphylococcal alpha hemolysin.
Bull Johns Hopkins Hosp. 1963 Jan;112:15-30.
引用本文的文献
1
A protein A based Staphylococcus aureus vaccine with improved safety.
Vaccine. 2021 Jun 29;39(29):3907-3915. doi: 10.1016/j.vaccine.2021.05.072. Epub 2021 Jun 1.
2
Protein A suppresses immune responses during Staphylococcus aureus bloodstream infection in guinea pigs.
mBio. 2015 Jan 6;6(1):e02369-14. doi: 10.1128/mBio.02369-14.
3
Vaccine protection of leukopenic mice against Staphylococcus aureus bloodstream infection.
Infect Immun. 2014 Nov;82(11):4889-98. doi: 10.1128/IAI.02328-14. Epub 2014 Sep 2.
4
Coagulases as determinants of protective immune responses against Staphylococcus aureus.
Infect Immun. 2012 Oct;80(10):3389-98. doi: 10.1128/IAI.00562-12. Epub 2012 Jul 23.
5
Measurement of personality and attitude: applications to clinical research.
Postgrad Med J. 1968 Apr;44(510):277-85. doi: 10.1136/pgmj.44.510.277.
本文引用的文献
1
Staphylococcus toxoid and pustular acne.
Lancet. 1951 Sep 29;2(6683):558-61. doi: 10.1016/s0140-6736(51)93113-3.
2
A study of 435 strains of Staphylococcus pyogenes with reference to factors which may contribute to pathogenicity.
J Pathol Bacteriol. 1954 Oct;68(2):431-43. doi: 10.1002/path.1700680217.
3
Polyvalent somatic antigen for the prevention of staphylococcal infection.
Can Med Assoc J. 1960 Jul 23;83(4):143-7.
4
Purification of free staphylococcal coagulase.
Biochem J. 1958 Sep;70(1):125-34. doi: 10.1042/bj0700125.
5
Treatment of boils with erythromycin and with antibiotic E 129.
Br Med J. 1958 Jul 12;2(5088):83-4. doi: 10.1136/bmj.2.5088.83.
6
Studies on staphylococci from hospital patients: II. Effect of antimicrobial therapy and hospitalization on carrier rates.
Ann N Y Acad Sci. 1956 Aug 31;65(3):206-21. doi: 10.1111/j.1749-6632.1956.tb36639.x.
7
Antistaphylocoagulase in experimental staphylococcal infections.
J Immunol. 1956 Feb;76(2):89-96.
8
Origin of penicillin-resistant Staphylococcus pyogenes.
Nature. 1955 Jul 23;176(4473):176. doi: 10.1038/176176a0.
9
Staphylococcal infections in general practice.
Br Med J. 1954 Dec 4;2(4900):1322-5. doi: 10.1136/bmj.2.4900.1322.
10
Bacteriophage typing of strains of staphylococci isolated in Australia.
Lancet. 1953 Mar 14;1(6759):514-6. doi: 10.1016/s0140-6736(53)92358-7.
Zotero 插件